Intravaginal ring providing dual protection is first of its kind to enter a clinical trial
Women’s reproductive health may never be the same, thanks to Northwestern University biomedical engineer Patrick Kiser and his first-of-its-kind intravaginal ring that reliably delivers an antiretroviral drug and a contraceptive for months.
Kiser’s one ring delivers two drugs that do three important things: the device is designed to protect against HIV and herpes as well as unwanted pregnancy. It will be the first device with the potential to offer this protection to be tested in women.
The easy-to-use ring delivers controlled doses of tenofovir (a common antiretroviral drug) and levonorgestrel (a contraceptive) for 90 days. The rings are being manufactured now, and the device soon will undergo its first test in women.
Details of the development of the ring, a device that represents a lot of ‘firsts,’ was published March 5 by PLOS ONE, a peer-reviewed, open-access online journal.
According to the World Health Organization, 35 million people around the world live with HIV, and 222 million women would like to delay or stop childbearing but are not using any method of contraception.
“I suspect women will use the ring primarily for contraception, but they also will benefit from protection against sexually transmitted diseases,” said Kiser, an expert in intravaginal drug delivery. “And for women in the developing world in particular, unwanted pregnancy can have significant health, economic and cultural consequences. We want to motivate women to use this ring.”
The ring, 5.5 centimeters in diameter, is simple yet complex. Kiser and his colleagues worked painstakingly for five years, engineering the three materials that make up the ring and optimizing the device to reliably deliver fixed and efficacious doses of two medicines over a long period of time.
“A lot of engineering has gone into developing the ring,” said Kiser, senior author of the paper. “It represents two Ph.D. theses — one Ph.D. for the larger section containing the antiretroviral drug and another Ph.D. for the smaller section containing the contraceptive.”
Kiser is a faculty member in the department of biomedical engineering at the McCormick School of Engineering and Applied Science and in the department of obstetrics and gynecology at Northwestern University Feinberg School of Medicine.
The ring is easily inserted in the vagina and stays in place for three months. And because the tenofovir is delivered at the site of transmission, the ring — known as the tenofovir levonorgestrel IVR — utilizes a smaller dose than pills. The levonorgestrel released by the ring is the same drug as that used in certain contraceptive pills and in an intrauterine device.
“This system represents a significant advance in vaginal drug delivery technology and is the first in a new class of long-acting multipurpose prevention drug delivery systems,” say the authors in the study. They also report details of the ring’s engineering, safety, stability and drug release.
“The differences between the two drugs are huge, which presented us with a design challenge,” Kiser said. “Tenofovir is highly water soluble while levonorgestrel is highly water insoluble. And the daily dose is different: the ring delivers about 10 milligrams of tenofovir and only 10 micrograms of levonorgestrel. Our scientific hurdle was finding a way to manufacture a dual-purpose ring that got the device into the clinic.”
Tenofovir is taken orally by 3.5 million HIV-infected people worldwide, and it also has been studied as a gel. The drug inhibits HIV and HSV-2 (herpes simplex virus-2) replication in susceptible cells.
Previous studies have demonstrated that antiretroviral drugs can prevent HIV infection, but existing methods for delivering the drug fall short. Pills must be taken daily and require high doses; some women may prefer a longer-lasting method, such as the ring, versus methods used at the time of sex, such as a gel.
Kiser’s combination ring promises much more. The strength of the device stems from its unique polymer construction: its elastomer swells in the presence of fluid (such as that found in the human body), delivering up to 100 times more of the tenofovir than current intravaginal ring technology, which have release rates that decline over time.
“Products only work when they are used,” said co-author David Friend, product development director at CONRAD, which develops reproductive health technologies for low-income countries and is affiliated with Eastern Virginia Medical School.
“By having a ring that can remain in the body for up to 90 days, our hope is that this ring will offer a solution to increase adherence, and therefore provide greater protection against HIV while also preventing pregnancy,” he said.
The Latest on: Birth control
via Google News
The Latest on: Birth control
- REPORT: Schools To Maintain Condom, Birth Control Availability For Fifth Graders In Chicagoon July 7, 2021 at 4:17 pm
As part of a policy passed in December by the Chicago Public Schools’ Board of Education, schools that teach fifth grade and up must maintain condom availability as part of an expanded sexual health ...
- Kansas City area birth center closes, limiting options for women of color, moms in needon July 7, 2021 at 3:16 pm
New Birth Company was serving roughly 100 moms as of July 1. About 40% of those mothers were Medicaid recipients. Now the facility is closing, leaving mothers in need with fewer options.
- Jersey Shore: Jenni 'JWoww' Farley Says She Doesn't Want More Kids — but Isn't on Birth Controlon July 7, 2021 at 11:45 am
Could more Jersey Shore babies be in the cards? In PEOPLE's exclusive sneak peek at Thursday's episode of Jersey Shore: Family Vacation, the girls head out to lunch, where the conversation ends up ...
- How An Anti-Vice Crusader Sabotaged The Early Birth Control...on July 7, 2021 at 11:24 am
A very common form of birth control that many women used was vaginal douching, which were these syringes. And you could use them for health and hygienic purposes, but they would also put various ...
- How An Anti-Vice Crusader Sabotaged The Early Birth Control Movementon July 7, 2021 at 9:50 am
The Comstock Act, which passed in 1873, virtually outlawed contraception. In The Man Who Hated Women, author Amy Sohn writes about the man behind the law — and the women prosecuted under it.
- Colorado will provide birth control, reproductive care for immigrants without documentationon July 6, 2021 at 1:17 pm
A new state program will help immigrants who are in the U.S. without legal permission to get access to more affordable — or even free — birth control and other reproductive care.
- Struggling With Acne and Thinking About Treating It With Birth Control? Dermatologists Suggest These Typeson July 6, 2021 at 9:34 am
There’s a ton of mixed messages surrounding birth control and acne. Some people will say it cleared their skin right up, while others actually find that their skin breaks out as a result of it.This is ...
- 3 Ways the Birth Control Pill Can Affect Your Sex Life, According to an OB/GYNon July 5, 2021 at 9:04 am
But there are also side effects that are less commonly discussed, and three of them affect your sex life. They’re not as dire as those above—and your doctor may not mention them—but they’re still ...
- Does Birth Control Make You Moody? It Can, but These Doctors Have Some Sound Advice for Dealing With Iton July 2, 2021 at 8:57 am
Before starting hormonal birth control, one of the main concerns women have is how it will impact their body and life overall. From worrying about scary side effects like blood clots to more ...
- The Anti–Birth Control Movement Is the New Anti-Abortion Movementon July 1, 2021 at 8:13 am
Republicans are “conflating medications that prevent pregnancy—birth control and emergency contraception—with medications that end pregnancy,” says the president of the Planned Parenthood Action Fund.
via Bing News